Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avi Leader

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Acta Oncologica (Stockholm, Sweden)|August 26, 2016
First line treatment with newer tyrosine kinase inhibitors in chronic myeloid leukemia associated with deep and durable molecular response - systematic review and meta-analysisRonit Gurion, Pia Raanani, Liat Vidal, et al.
Drug Safety|January 25, 2024
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic ReviewBronya Calvarysky, Idit Dotan, Daniel Shepshelovich, et al.
Acta Haematologica|December 11, 2024
Clinical Challenges in Treating Cancer-Associated Thrombosis: A Clinically Oriented ReviewIdan Goldberg, Galia Spectre, Pia Raanani, et al.
Cardio-Oncology (London, England)|February 3, 2021
Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemiaOren Pasvolsky, Avi Leader, Zaza Iakobishvili, et al.
Cardio-Oncology (London, England)|February 3, 2021
Hypertension in cancer patients treated with anti-angiogenic based regimensYishay Wasserstrum, Ran Kornowski, Pia Raanani, et al.
Cancer Medicine|August 13, 2024
Romiplostim in chemotherapy-induced thrombocytopenia: A review of the literatureGerald A Soff, Hanny Al-Samkari, Avi Leader, et al.
The Journal of Clinical Endocrinology and Metabolism|June 3, 2014
Thyrotropin levels within the lower normal range are associated with an increased risk of hip fractures in euthyroid women, but not men, over the age of 65 yearsAvi Leader, Racheli Heffez Ayzenfeld, Michael Lishner, et al.
Journal of Thrombosis and Thrombolysis|December 21, 2023
Efficacy and safety of rivaroxaban versus apixaban for venous thromboembolism: A systematic review and meta-analysis of observational studiesDanielle Fredman, Rotem McNeil, Ofir Eldar, et al.
Coronary Artery Disease|May 17, 2019
Mean platelet volume and clinical outcomes of patients with chest pain discharged from internal medicine wardsGil Beeri, Guy Topaz, Alon Y Hershko, et al.
Annals of Hematology|October 6, 2021
Targeted therapies for immune thrombocytopenic purpura: a meta-analysis of randomized controlled trialsInbar Cohen, Hadar Goldvaser, Ilya Kirgner, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Acta Oncologica (Stockholm, Sweden)|August 26, 2016
First line treatment with newer tyrosine kinase inhibitors in chronic myeloid leukemia associated with deep and durable molecular response - systematic review and meta-analysisRonit Gurion, Pia Raanani, Liat Vidal, et al.
Drug Safety|January 25, 2024
Drug-Drug Interactions Between Glucagon-Like Peptide 1 Receptor Agonists and Oral Medications: A Systematic ReviewBronya Calvarysky, Idit Dotan, Daniel Shepshelovich, et al.
Acta Haematologica|December 11, 2024
Clinical Challenges in Treating Cancer-Associated Thrombosis: A Clinically Oriented ReviewIdan Goldberg, Galia Spectre, Pia Raanani, et al.
Cardio-Oncology (London, England)|February 3, 2021
Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemiaOren Pasvolsky, Avi Leader, Zaza Iakobishvili, et al.
Cardio-Oncology (London, England)|February 3, 2021
Hypertension in cancer patients treated with anti-angiogenic based regimensYishay Wasserstrum, Ran Kornowski, Pia Raanani, et al.
Cancer Medicine|August 13, 2024
Romiplostim in chemotherapy-induced thrombocytopenia: A review of the literatureGerald A Soff, Hanny Al-Samkari, Avi Leader, et al.
The Journal of Clinical Endocrinology and Metabolism|June 3, 2014
Thyrotropin levels within the lower normal range are associated with an increased risk of hip fractures in euthyroid women, but not men, over the age of 65 yearsAvi Leader, Racheli Heffez Ayzenfeld, Michael Lishner, et al.
Journal of Thrombosis and Thrombolysis|December 21, 2023
Efficacy and safety of rivaroxaban versus apixaban for venous thromboembolism: A systematic review and meta-analysis of observational studiesDanielle Fredman, Rotem McNeil, Ofir Eldar, et al.
Coronary Artery Disease|May 17, 2019
Mean platelet volume and clinical outcomes of patients with chest pain discharged from internal medicine wardsGil Beeri, Guy Topaz, Alon Y Hershko, et al.
Annals of Hematology|October 6, 2021
Targeted therapies for immune thrombocytopenic purpura: a meta-analysis of randomized controlled trialsInbar Cohen, Hadar Goldvaser, Ilya Kirgner, et al.
Pageof 9